세계의 DNA 치료제 시장 : 약물 유형별, 용도별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2023-2030년)

DNA Repair Drugs Market with COVID-19 Impact Analysis, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,590,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,568,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,980,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 DNA 치료제 시장 규모는 2022년 60억 520만 달러에 달했으며, 2023-2030년까지 CAGR 12.8%의 성장률을 나타낼 것으로 예상됩니다.

DNA 치료제 시장 - 시장 역학

• 암 환자 증가와 의료 인프라의 정비로 시장 수요 증가
• 세계적으로 암 발생이 증가함에 따라 암의 미충족 수요를 해결하기 위해 DNA 손상 반응성 약물을 개발할 필요성이 크게 증가하고 있습니다. 이러한 약물은 암의 생존율을 높이기 위해 특이적이고 효과적으로 내약성이 있는 치료법을 제공할 수 있는 전례 없는 잠재력을 가지고 있습니다. 또한, DNA 복구 약물은 종종 환자의 유전적 체질이나 특정 변이에 따라 의료를 개별화하는 개인 맞춤형 의료의 개념과 관련이 있습니다. 따라서 약물은 선택적 유전자 프로파일에 맞게 설계될 수 있습니다. 결과적으로 이러한 추세는 이러한 약물의 잠재적 시장을 촉진하는 데 도움이 될 수 있습니다. 그러나 시장 관계자들에게는 DNA 복구 약물에 대한 규제 당국의 승인을 얻는 것은 시간이 많이 걸리고 복잡한 과정이기 때문에 세계 시장 성장을 억제할 수 있습니다. 또한, 신흥국의 의료비 증가와 의료 인프라의 성장은 DNA 복구 약물 제조업체에 큰 성장 기회를 제공합니다. 또한, 이들 지역에서는 효과적인 치료법에 대한 미충족 수요가 존재하고, 방대한 환자 인구가 양호한 시장 환경을 조성하고 있어 DNA 복구 시장의 성장을 가속할 것으로 예상됩니다.

DNA 치료제 시장 - 세분화 분석

• 세계 DNA 복구 약물 시장은 약물 유형, 용도, 유통 채널, 지역별로 분류됩니다.
• 약물 유형에 따라 알킬화제, PARP 억제제, 토포이소머라제 억제제, 기타로 분류됩니다. 시장 세분화에서는 PARP 억제제가 가장 큰 점유율을 차지하고 있습니다. 상동 재조합 복구(HRR) 경로와 전이성 전립선암, 삼중음성 유방암 등을 표적으로 하는 PARP 억제제의 사용은 시장 규모를 확대할 것으로 예상됩니다. 또한, 오라파립, 니라파립, 루카파립 등의 PARP 억제제가 BRCA1/2 유전자 돌연변이 및 HRR 결손을 가진 암 환자들에게 사용되면서 이 분야 시장 규모가 확대될 것으로 예상됩니다.
• 시장은 용도별로 신경 퇴행성 질환, 암, 심혈관 질환, 뇌졸중 등 4개 분야로 분류됩니다. 심혈관 질환 분야는 예측 기간 동안 우위를 유지할 것으로 예상되며, DNA 복구 약물은 파킨슨병, 알츠하이머병과 같은 여러 유형의 심혈관 질환을 치료할 수 있는 잠재력을 가지고 있습니다. 또한, DNA 복구를 통해 치료 옵션을 제공할 가능성도 있습니다.
• 이 시장은 유통 채널에 따라 소매 약국, 병원 약국, 기타 두 가지로 나뉩니다. 접객 부문은 빠르게 성장할 것으로 예상됩니다. 이 부문의 성장은 암의 유병률 증가에 기인합니다. 또한, 이러한 약물은 특수하고 부작용이 있을 수 있기 때문에 모니터링과 신중한 취급 및 투여가 필요합니다.

DNA 치료제 시장 - 지리적 통찰력

지리적으로는 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이들 지역은 사업 진출 국가에 따라 더욱 세분화되어 있습니다.

DNA 치료제 시장 - 경쟁 구도

DNA 치료제 시장은 주요 기업의 존재로 인해 세계적으로 매우 집중되어 있습니다. 또한, 다양한 제조업체들이 각 지역에서 큰 점유율을 차지하고 있습니다. 선진국 시장뿐만 아니라 신흥국 시장에서도 암 발병률 증가로 인해 기술적으로 진보된 제품에 대한 수요가 증가하고 있습니다. 시장 기업들이 채택하는 성장 전략이 세계 시장을 주도할 가능성이 높습니다. 이에 따라 M&A, 혁신적 제품 출시, R&D 활동, 제휴 등의 전략이 포함될 것으로 보입니다. 예를 들어, 2022년 3월 플로리다 주립대 의대 연구진은 신체의 DNA 복구 과정이 어떻게 작동하는지에 대한 이해를 변화시키는 발견을 했으며, 이는 암 및 기타 질병에 대한 새로운 화학 요법 치료로 이어질 수 있습니다.

목차

제1장 DNA 치료제 시장 개요

• 조사 범위
• 시장 추정 연도

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 DNA 치료제 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 DNA 치료제 업계 조사

• PEST 분석
• Porter의 Five Forces 분석
• 성장 전망 매핑
• 규제 구조 분석

제5장 DNA 치료제 시장 : COVID-19의 영향 분석

• 신형 코로나바이러스 이전의 영향 분석
• 신형 코로나바이러스 이후의 영향 분석

제6장 DNA 치료제 시장 구도

• DNA 치료제 시장 점유율 분석, 2022년
• 주요 제조업체별 분석 데이터
  • 기존 기업 분석
  • 신규 기업 분석

제7장 DNA 치료제 시장 - 약제 유형별

• 개요
  • 약제 유형별 부문 점유율 분석
  • 알킬화제
  • PARP 저해제
  • 트포이소메라제 저해제
  • 기타

제8장 DNA 치료제 시장 - 용도별

• 개요
  • 용도별 부문 점유율 분석
  • 신경 퇴행성 질환
  • 종양
  • 심혈관질환
  • 뇌졸중

제9장 DNA 치료제 시장 - 유통 채널별

• 개요
  • 유통 채널별 부문 점유율 분석
  • 소매 약국
  • 병원 약국
  • 기타

제10장 DNA 치료제 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제11장 주요 벤더 분석 - DNA 치료제 업계

• 경쟁 대시보드
• 기업 개요
  • Johnson &Johnson
  • Merck Kgaa
  • GlaxoSmithKline plc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Amgen Inc.
  • Astrazeneca plc
  • Bristol-Myers Squibb Co.
  • Sanofi SA
  • Bayer AG
  • Eli Lilly
  • Gilead Sciences Inc.
  • Merck &Co. Inc.
  • Novartis AG

제12장 애널리스트 전방위 전망

LSH

영문 목차

영문목차

REPORT HIGHLIGHT

DNA repair drugs market size was valued at USD 6,005.2 Million in 2022, expanding at a CAGR of 12.8% from 2023 to 2030.

DNA repair drugs are defined as a class of pharmaceuticals that purpose to restore DNA functionality and integrity by helping to repair damaged DNA molecules. Moreover, these drugs are targeting particular DNA repair pathways and assist to restore DNA integrity as well as preventing the progression and development of several diseases, including cancer. The DNA repair drugs market is likely to witness significant growth due to increasing advancements and research activities in the field of molecular and genomics biology.

DNA Repair Drugs Market- Market Dynamics:

• Increasing cases of cancer and growing healthcare infrastructure to fuel the market demand.

• The increasing cases of cancer across the world have significantly raised the requirement for developing DNA damage response drugs for solving cancer unmet needs. These medications have hitherto unheard-of potential in providing a specific and effectively tolerated therapy method for boosting cancer survival rates. Moreover, DNA repair drugs are frequently associated with the idea of personalized medicine, where medical care is individualized based on a patient's genetic makeup as well as particular mutations. Thus, the drugs can be designed for selective genetic profiles; as a result, this trend helps to boost the potential market for these drugs. However, for market players, procuring regulatory approvals for DNA repair drugs could be a time-consuming and complex process that may restrain the market growth globally. Furthermore, the increasing healthcare expenditure and growing healthcare infrastructure in the emerging nation offer significant growth opportunities for DNA repair drug manufacturers. Additionally, these regions have an unmet need for effective treatments and a huge patient population creating a favorable market environment, which is projected to boost the DNA repair market growth.

DNA Repair Drugs Market- Key Insights:

• As per the analysis shared by our research analyst, the global DNA repair drugs market is estimated to grow annually at a CAGR of around 12.8% over the forecast period (2023-2030)

• The DNA repair drugs industry is projected to grow at a significant rate due to the rising incidence and prevalence of several cancers among the population increase the demand

• Based on drug type segmentation, PARP inhibitors was predicted to show maximum market share in the near future

• Based on application segmentation, cardiovascular diseases was the leading type in 2022

• On the basis of region, North America was the leading revenue generator during the forecast period

DNA Repair Drugs Market- Segmentation Analysis:

• The global DNA repair drugs market is segmented on the basis of drug type, application, distribution channel, and region.

• The market is divided into three categories based on drug type: alkylating agents, PARP inhibitors, topoisomerase inhibitors, and others. The PARP inhibitors segment is likely to possess the market share. The use of PARP inhibitors to target homologous recombination repair (HRR) pathways, tumors extensively in metastatic prostate cancer, and triple-negative breast cancer is expected to augment the market size over. Additionally, the utilization of PARP inhibitors including olaparib, niraparib, and rucaparib, in cancer patients with BRCA1/2 mutation and deficiency in HRR is projected to strengthen the segment value.

• The market is divided into four categories based on application: neurodegenerative diseases, oncological, cardiovascular diseases, and stroke. The cardiovascular diseases segment is expected to maintain its dominance over the forecast period. DNA repair drugs have the potential in treating numerous types of cardiovascular diseases like Parkinson's and Alzheimer's. Moreover, therapeutic options could be provided by DNA repair.

• The market is divided into two categories based on distribution channels: retail pharmacies, hospital pharmacies, and others. The hospital pharmacies segment is accounted to witness speedy growth. The segment growth is attributed due to the rising prevalence of cancer. Moreover, the specific nature of these drugs and their potential side effects, are likely to require monitoring, careful handling, and administration, as a result, such factors may propel the hospital pharmacies segment growth.

DNA Repair Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

DNA Repair Drugs Market- Competitive Landscape:

The DNA repair drugs market is highly concentrated across the globe owing to the presence of key players. Additionally, various manufacturers hold a major share in their respective regions. Demand for technologically advanced products has increased in developed as well as emerging markets, due to the increase in the prevalence of cancer. Growth strategies adopted by market players are likely to drive the global market. In line with this, the strategies include mergers & acquisitions, innovative product launches, R&D activities, and partnerships. For instance, in March 2022, a Florida State University College of Medicine researcher made a discovery that alters our understanding of how the body's DNA repair process works and may lead to new chemotherapy treatments for cancer and other diseases.

Recent Developments:

Furthermore, in February 2023, Artios Pharma Limited (Artios) introduced the initiation of a randomized, Phase 2 expansion cohort in the ongoing Phase 1/2 trial evaluating its ataxia telangiectasia and Rad3-related ("ATR") Inhibitor, ART0380, for the treatment of platinum-resistant ovarian cancer in combination with gemcitabine.

Key features of the study:

• This proposed research study on DNA repair drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

• The report provides the client the latest up-to-date and trending insights about the DNA repair drugs market..

• The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for DNA repair drugs market.

• The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the DNA repair drugs market.

• Impact of COVID-19 on DNA repair drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on DNA repair drugs market post-COVID will also be covered.

• In order to give the users of this report a comprehensive view on the DNA repair drugs market, we have also included competitive landscape and key innovator analysis for the DNA repair drugs market.

• The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

• The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the DNA repair drugs market.

• In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

• The global DNA repair drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DNA REPAIR DRUGS MARKET KEY PLAYERS

• Johnson & Johnson
• Merck Kgaa
• GlaxoSmithKline plc
• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Abbvie Inc.
• Pfizer Inc.
• Amgen Inc.
• Astrazeneca plc
• Bristol-Myers Squibb Co.
• Sanofi S.A.
• Bayer AG
• Eli Lilly
• Gilead Sciences Inc.
• Merck & Co. Inc.
• Novartis AG

GLOBAL DNA REPAIR DRUGS MARKET, BY DRUG TYPE

• Alkylating Agents
• PARP Inhibitors
• Topoisomerase Inhibitors
• Other

GLOBAL DNA REPAIR DRUGS MARKET, BY APPLICATION

• Neurodegenerative Diseases
• Oncological
• Cardiovascular Diseases
• Stroke

GLOBAL DNA REPAIR DRUGS MARKET, BY DISTRIBUTION CHANNEL

• Retail Pharmacies
• Hospital Pharmacies
• Others

GLOBAL DNA REPAIR DRUGS MARKET, BY REGION

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. DNA Repair Drugs Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. DNA Repair Drugs Market Snippet by Drug Type
  • 2.1.2. DNA Repair Drugs Market Snippet by Application
  • 2.1.3. DNA Repair Drugs Market Snippet by Distribution Channel
  • 2.1.4. DNA Repair Drugs Market Snippet by Country
  • 2.1.5. DNA Repair Drugs Market Snippet by Region
• 2.2. Competitive Insights

3. DNA Repair Drugs Key Market Trends

• 3.1. DNA Repair Drugs Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. DNA Repair Drugs Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. DNA Repair Drugs Market Opportunities
• 3.4. DNA Repair Drugs Market Future Trends

4. DNA Repair Drugs Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. DNA Repair Drugs Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. DNA Repair Drugs Market Landscape

• 6.1. DNA Repair Drugs Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. DNA Repair Drugs Market - By Drug Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Drug Type, 2022&2030 (%)
  • 7.1.2. Alkylating Agents
  • 7.1.3. PARP Inhibitors
  • 7.1.4. Topoisomerase Inhibitors
  • 7.1.5. Other

8. DNA Repair Drugs Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
  • 8.1.2. Neurodegenerative Diseases
  • 8.1.3. Oncological
  • 8.1.4. Cardiovascular Diseases
  • 8.1.5. Stroke

9. DNA Repair Drugs Market - By Distribution Channel

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
  • 9.1.2. Retail Pharmacies
  • 9.1.3. Hospital Pharmacies
  • 9.1.4. Others

10. DNA Repair Drugs Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. DNA Repair Drugs Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. DNA Repair Drugs Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. DNA Repair Drugs Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. DNA Repair Drugs Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. DNA Repair Drugs Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- DNA Repair Drugs Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Johnson & Johnson
  • 11.2.2. Merck Kgaa
  • 11.2.3. GlaxoSmithKline plc
  • 11.2.4. Abbott Laboratories
  • 11.2.5. F. Hoffmann-La Roche Ltd.
  • 11.2.6. Abbvie Inc.
  • 11.2.7. Pfizer Inc.
  • 11.2.8. Amgen Inc.
  • 11.2.9. Astrazeneca plc
  • 11.2.10. Bristol-Myers Squibb Co.
  • 11.2.11. Sanofi S.A.
  • 11.2.12. Bayer AG
  • 11.2.13. Eli Lilly
  • 11.2.14. Gilead Sciences Inc.
  • 11.2.15. Merck & Co. Inc.
  • 11.2.16. Novartis AG

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us

관련자료